Increasing lung cancer screening through social media interventions
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
This study is testing if using social media ads can help encourage smokers and recent quitters to get screened for lung cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 1 site (Nutley, New Jersey) |
| Trial ID | NCT05824273 on ClinicalTrials.gov |
What this trial studies
The INSPIRE-Lung Study aims to enhance lung cancer screening rates among high-risk individuals by utilizing innovative communication strategies, specifically through the LungTalk program and Facebook-targeted advertisements. This interventional approach seeks to engage smokers and recent quitters with tailored messaging to encourage screening uptake. The study targets individuals with a significant smoking history, focusing on those who may not have previously participated in lung cancer screening. By leveraging social media, the study hopes to reach a broader audience and improve awareness about lung cancer risks and screening options.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older with a smoking history of 20 pack-years or more, including current smokers and those who have quit within the last 15 years.
Not a fit: Patients who have previously been diagnosed with lung cancer or have undergone lung cancer screening via LDCT are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase the number of high-risk individuals who undergo lung cancer screening, potentially leading to earlier detection and better outcomes.
How similar studies have performed: Other studies utilizing social media and targeted interventions for cancer screening have shown promise, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥20-pack-year smoking history; * Individuals who currently smoke or quit smoking within the past 15 years Exclusion Criteria: * Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed * Has ever been diagnosed with lung cancer * Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)
Where this trial is running
Nutley, New Jersey
- Hackensack Meridian Health - Center for Discovery and Innovation — Nutley, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Lisa Carter-Bawa, PhD — Hackensack Meridian Health
- Study coordinator: Francis Valenzona
- Email: francis.valenzona@hmh-cdi.org
- Phone: 2018803400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.